Mellicell

Developer of regenerative therapy for diabetes mellitus

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups8 employees language mellicell.com

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 13 times.

YearFilings
20221
20242
20252

Social engagement

Social engagement: 786 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%

Recent activity

3 Jun 2026
Recognition
2 Mar 2026
Event
March Madness
Coming soon